Jeremy Veenstra-VanderWeele uses molecular and translational neuroscience research tools in the pursuit of new treatments for autism.
Jeremy Veenstra-VanderWeele
From this contributor
Why serotonin medications may yet help children with autism
A class of medications used to treat obsessive-compulsive disorder seems to ease compulsive behaviors in adults with autism. Why can't we tell if these medications work similarly in children with the condition?
Why serotonin medications may yet help children with autism
How to evaluate new medications for autism
There are no available medications for treating autism’s core symptoms, but there are several candidates in clinical trials. Jeremy Veenstra-VanderWeele describes the factors researchers must take into account when developing drugs for the disorder.
How to evaluate new medications for autism
Explore more from The Transmitter
Acetaminophen effects on developing brain organoids; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 12 October.
Acetaminophen effects on developing brain organoids; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 12 October.
Private initiative makes ‘historic’ investment in autism research
Aligning Research to Impact Autism has committed more than $450 million to build a new multidisciplinary research network to uncover the roots of profound autism and develop treatments.
Private initiative makes ‘historic’ investment in autism research
Aligning Research to Impact Autism has committed more than $450 million to build a new multidisciplinary research network to uncover the roots of profound autism and develop treatments.
The neural code at 100
In two 1926 articles, Edgar Douglas Adrian revealed that neurons communicate through trains of spikes.
The neural code at 100
In two 1926 articles, Edgar Douglas Adrian revealed that neurons communicate through trains of spikes.